PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
16-Apr-2024 PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis PureTech Health plc
16-Apr-2024 Mundipharma and Vectura announce plans to reformulate flutiform® (fluticasone propionate/formoterol fumarate) pressurised metereddose inhaler (pMDI) as a commitment to reducing the product’s carbon footprint Mundipharma and Vectura
16-Apr-2024 ELRIG UK and SRG Announce Partnership to Advance Life Science Professionals in Drug Discovery ELRIG UK
16-Apr-2024 Serum Institute of India and University of Oxford Strike Landmark Licensing Agreement for Meningitis-B Vaccine Serum Institute of India and University of Oxford
16-Apr-2024 Nxera Pharma Notes Successful Development Progress of Partnered Schizophrenia Candidate NBI-1117568 Nxera Pharma
16-Apr-2024 GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY-LED INITIATIVES IN ASIA GILEAD
16-Apr-2024 ELRIG UK and SRG Announce Partnership to Advance Life Science Professionals in Drug Discovery ELRIG UK and SRG
15-Apr-2024 Germfree and Orgenesis announce asset purchase and strategic partnership intended to revolutionize cell and gene therapy through decentralized production and global accessibility Germfree and Orgenesis
15-Apr-2024 Dot Compliance Raises a $17.5 Million Up-Round in Series B Extension Funding to Advance New Category of AI-driven Compliance Dot Compliance
15-Apr-2024 FASENRA approved for treatment of children aged 6 to 11 with severe asthma - Additional indication for pediatric patients with severe eosinophilic asthma Astrazeneca
15-Apr-2024 PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers PureTech Health plc
15-Apr-2024 PHARMACISTS SAY REGULATED APPROACH TO E-LABELLING IS KEY TO SUCCESSFUL TRANSITION Weber Shandwick
15-Apr-2024 Century Therapeutics to acquire Clade Therapeutics Syncona Limited
11-Apr-2024 AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock AdrenoMed AG
11-Apr-2024 New insight into combatting drug-resistant prostate cancer University of Eastern Finland
11-Apr-2024 EFA Technologies, pioneer in portable blood labs, enters Brazilian market after Anvisa approval of its portable RevDx device EFA Technologies
11-Apr-2024 Qinecsa Host Industry Discussion on Mastering Medical Device Regulations to Integrate Devices into Pharma Portfolios Qinecsa
11-Apr-2024 Qinecsa Solutions announces acquisition of Insife to expand its end-to-end pharmacovigilance technology solutions Qinecsa
11-Apr-2024 AbbVie’s AQUIPTA® (atogepant) Is Recommended By NICE For The Prevention Of Migraine In Adults AbbVie
09-Apr-2024 Gilead extends partnership with NHS England to eliminate hepatitis C by 2025 Gilead Sciences, Inc